Is the CRAFITY score a superior predictor of prognosis and adverse events in hepatocellular carcinoma patients treated with locoregional-immunotherapy?

被引：0
|
作者：
Renguo Guan
Jie Mei
Wenping Lin
Min Deng
Shaohua Li
Rongping Guo
机构：
[1] Sun Yat-sen University Cancer Center,Department of Hepatobiliary Oncology
[2] State Key Laboratory of Oncology in South China,undefined
[3] Collaborative Innovation Center for Cancer Medicine,undefined
来源：
Hepatology International | 2023年 / 17卷
关键词：
Hepatocellular carcinoma; Programmed cell death 1; Hepatic arterial infusion chemotherapy; Transhepatic arterial chemotherapy and embolization; C‑reactive protein; Alpha‑fetoprotein; C‑reactive protein and alpha‑fetoprotein in immunotherapy score; Adverse events; Overall survival; Progression-free survival;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1279 / 1288
页数：9
相关论文
共 50 条
  • [41] The CRAFITY score to predict hepatocellular carcinoma disease control rate at month 12 in patients undergoing transarterial chemoembolization
    Veelken, Rhea
    Olbrich, Anne
    Lieb, Sabine
    Schindler, Aaron
    Herber, Adam
    Ebel, Sebastian
    Denecke, Timm
    Berg, Thomas
    van Bommel, Florian
    JOURNAL OF HEPATOLOGY, 2024, 80 : S404 - S404
  • [42] Body mass index, as a novel predictor of hepatocellular carcinoma patients treated with Anti-PD-1 immunotherapy
    Chen, Jierong
    Lu, Lianghe
    Qu, Chunhua
    Gari, A.
    Deng, Fangqi
    Cai, Muyan
    Chen, Wei
    Zheng, Lie
    Chen, Jiewei
    FRONTIERS IN MEDICINE, 2022, 9
  • [43] Immunotherapy in hepatocellular carcinoma: evaluation and management of adverse events associated with atezolizumab plus bevacizumab
    Hsu, Chiun
    Rimassa, Lorenza
    Sun, Hui-Chuan
    Vogel, Arndt
    Kaseb, Ahmed O.
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2021, 13
  • [44] Clinicogenomic predictors of outcomes in patients with hepatocellular carcinoma treated with immunotherapy
    Cowzer, Darren
    Chou, Joanne F.
    Walch, Henry
    Keane, Fergus
    Khalil, Danny
    Shia, Jinru
    Do, Richard K. G.
    Yarmohammadi, Hooman
    Erinjeri, Joseph P.
    El Dika, Imane
    Yaqubie, Amin
    Azhari, Hassan
    Gambarin, Maya
    Hajj, Carla
    Crane, Christopher
    Wei, Alice C.
    Jarnagin, William
    Solit, David B.
    Berger, Michael F.
    O'Reilly, Eileen M.
    Schultz, Nikolaus
    Chatila, Walid
    Capanu, Marinela
    Abou-Alfa, Ghassan K.
    Harding, James J.
    ONCOLOGIST, 2024, 29 (10): : 894 - 903
  • [45] Modified BALAD Score Predicts Incomplete Locoregional Therapy Treatment in Hepatocellular Carcinoma Patients
    Nunez, Kelley
    Sandow, Tyler
    Robertson, Sarah
    Thevenot, Paul
    Cohen, Ari
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 72 - 73
  • [46] Impact of immune-related adverse events in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab
    Suzuki, Keito
    Yasui, Yutaka
    Tsuchiya, Kaoru
    Matsumoto, Hiroaki
    Yamazaki, Yudai
    Uchihara, Naoki
    Tanaka, Yuki
    Miyamoto, Haruka
    Yamada-Shimizu, Michiko
    Keitoku, Taisei
    Okada, Risa
    Higuchi, Mayu
    Takaura, Kenta
    Tanaka, Shohei
    Maeyashiki, Chiaki
    Tamaki, Nobuharu
    Nakanishi, Hiroyuki
    Takahashi, Yuka
    Asahina, Yasuhiro
    Okamoto, Ryuichi
    Kurosaki, Masayuki
    Izumi, Namiki
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024, 39 (06) : 1183 - 1189
  • [47] Clinical Significance of Adverse Events for Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib: A Multicenter Retrospective Study
    Shimose, Shigeo
    Iwamoto, Hideki
    Niizeki, Takashi
    Shirono, Tomotake
    Noda, Yu
    Kamachi, Naoki
    Okamura, Shusuke
    Nakano, Masahito
    Suga, Hideya
    Kuromatsu, Ryoko
    Yamaguchi, Taizo
    Kawaguchi, Takumi
    Tanaka, Masatoshi
    Noguchi, Kazunori
    Koga, Hironori
    Torimura, Takuji
    CANCERS, 2020, 12 (07) : 1 - 15
  • [48] Leaky Gut and Severe Adverse Events in Advanced Hepatocellular Carcinoma Treated With Lenvatinib
    Fujimoto, Yuki
    Namisaki, Tadashi
    Takeda, Soichi
    Murata, Koji
    Enomoto, Masahide
    Takaya, Hiroaki
    Tsuji, Yuki
    Fujinaga, Yukihisa
    Sawada, Yasuhiko
    Nishimura, Norihisa
    Kitagawa, Koh
    Kaji, Kosuke
    Inoue, Takashi
    Kawaratani, Hideto
    Moriya, Kei
    Akahane, Takemi
    Mitoro, Akira
    Yoshiji, Hitoshi
    ANTICANCER RESEARCH, 2022, 42 (10) : 4895 - 4905
  • [49] Prognosis of patients with cirrhosis and hepatocellular carcinoma treated with resective surgery
    Pittau, S
    Andorno, S
    Maduli, E
    Morelli, S
    Rigamonti, C
    Giacalone, A
    Zaccala, G
    Sartori, M
    JOURNAL OF HEPATOLOGY, 2001, 34 : 233 - 234
  • [50] Inflammation–nutrition score predicts prognosis of patients with resectable hepatocellular carcinoma
    Xiao-Chun Ni
    Jie Xu
    Yong Yi
    Yi-Peng Fu
    Xiao-Yan Cai
    Gao Liu
    Jin-Long Huang
    Wei Gan
    Shuang-Jian Qiu
    International Journal of Clinical Oncology, 2019, 24 : 825 - 835
12345